TY - JOUR
T1 - Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody
AU - Witters, Lois M.
AU - Kumar, Rakesh
AU - Chinchilli, Vernon M.
AU - Lipton, Allan
PY - 1997
Y1 - 1997
N2 - HER-2/neu overexpression has been associated with poor prognosis in human breast cancer. Many of these cancers are also ER-positive. A logical therapeutic approach for patients who are ER-positive and overexpress HER-2/neu may be to block both the ER and the HER-2/neu pathways. In our study, we used both the MTT tetrazolium dye assay and 3H-thymidine incorporation to measure the effects of the anti-estrogen Tamoxifen or the 4D5 anti-HER-2/neu antibody alone or in combination on the growth of BT474 human breast cancer cells which express ER and overexpress HER-2/neu. We found an enhanced inhibitory effect on cell proliferation with the combination of Tamoxifen and the antibody compared to that seen by either agent alone. This simultaneous interruption of both the ER and the HER-2/neu pathways may be relevant in the clinical treatment of patients who are both ER-positive and overexpress HER-2/neu.
AB - HER-2/neu overexpression has been associated with poor prognosis in human breast cancer. Many of these cancers are also ER-positive. A logical therapeutic approach for patients who are ER-positive and overexpress HER-2/neu may be to block both the ER and the HER-2/neu pathways. In our study, we used both the MTT tetrazolium dye assay and 3H-thymidine incorporation to measure the effects of the anti-estrogen Tamoxifen or the 4D5 anti-HER-2/neu antibody alone or in combination on the growth of BT474 human breast cancer cells which express ER and overexpress HER-2/neu. We found an enhanced inhibitory effect on cell proliferation with the combination of Tamoxifen and the antibody compared to that seen by either agent alone. This simultaneous interruption of both the ER and the HER-2/neu pathways may be relevant in the clinical treatment of patients who are both ER-positive and overexpress HER-2/neu.
UR - http://www.scopus.com/inward/record.url?scp=0031015394&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031015394&partnerID=8YFLogxK
U2 - 10.1023/A:1005798224288
DO - 10.1023/A:1005798224288
M3 - Article
C2 - 9116313
AN - SCOPUS:0031015394
SN - 0167-6806
VL - 42
SP - 1
EP - 5
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 1
ER -
